Independent Drug Value Assessment Act of 2024

House Bill 6977 - Independent Drug Value Assessment Act of 2024: Overview, Status, and Impact

Hozzl · 2024-02-06T18:30:46Z

Explore the details of House Bill 6977 Independent Drug Value Assessment Act of 2024 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/6/2024, 6:30 PM

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6977

Bill HR 6977 is currently in the status of Bill Introduced since January 11, 2024. Bill HR 6977 was introduced during Congress 118 and was introduced to the House on January 11, 2024. Bill HR 6977's most recent activity was Referred to the House Committee on Energy and Commerce. as of January 11, 2024

Bipartisan Support of Bill HR 6977

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6977

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 6977

Independent Drug Value Assessment Act of 2024

To amend the Public Health Service Act to provide for a demonstration project for the development and publication of independent value assessments for drugs, and for other purposes.